Guest guest Posted April 21, 2011 Report Share Posted April 21, 2011 NS5A inhibitors: A new breakthrough for the treatment of chronic hepatitis C Journal of Hepatology Vitamin D deficiency and a CYP27B1–1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon–alfa based therapy Journal of Hepatology Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 21, 2011 Report Share Posted April 21, 2011 NS5A inhibitors: A new breakthrough for the treatment of chronic hepatitis C Journal of Hepatology Vitamin D deficiency and a CYP27B1–1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon–alfa based therapy Journal of Hepatology Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 21, 2011 Report Share Posted April 21, 2011 NS5A inhibitors: A new breakthrough for the treatment of chronic hepatitis C Journal of Hepatology Vitamin D deficiency and a CYP27B1–1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon–alfa based therapy Journal of Hepatology Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 21, 2011 Report Share Posted April 21, 2011 NS5A inhibitors: A new breakthrough for the treatment of chronic hepatitis C Journal of Hepatology Vitamin D deficiency and a CYP27B1–1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon–alfa based therapy Journal of Hepatology Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.